[	0	1	O
Photodynamic	1	13	O
therapy	14	21	O
in	22	24	O
severe	25	31	O
chronic	32	39	O
central	40	47	O
serous	48	54	O
chorioretinopaty	55	71	O
]	71	72	O

OBJECTIVE	74	83	O
:	83	84	O
To	85	87	O
determine	88	97	O
the	98	101	O
efficacy	102	110	O
of	111	113	O
Photodynamic	114	126	O
Therapy	127	134	O
(	135	136	O
PDT	136	139	O
)	139	140	O
in	141	143	O
chronic	144	151	O
Central	152	159	O
Serous	160	166	O
Chorioretinopathy	167	184	O
(	185	186	O
CSC	186	189	O
)	189	190	O
.	190	191	O

METHODS	192	199	O
:	199	200	O
Patients	201	209	B-Organism
diagnosed	210	219	O
with	220	224	O
chronic	225	232	O
CSC	233	236	O
,	236	237	O
with	238	242	O
clinical	243	251	O
evidence	252	260	O
of	261	263	O
activity	264	272	O
and	273	276	O
treated	277	284	O
with	285	289	O
Photodynamic	290	302	O
Therapy	303	310	O
,	310	311	O
are	312	315	O
included	316	324	O
in	325	327	O
this	328	332	O
report	333	339	O
.	339	340	O

All	341	344	O
were	345	349	O
assessed	350	358	O
by	359	361	O
a	362	363	O
complete	364	372	O
ophthalmological	373	389	O
examination	390	401	O
,	401	402	O
including	403	412	O
assessment	413	423	O
of	424	426	O
the	427	430	O
best	431	435	O
corrected	436	445	O
visual	446	452	O
acuity	453	459	O
(	460	461	O
BCVA	461	465	O
)	465	466	O
using	467	472	O
an	473	475	O
ETDRS	476	481	O
chart	482	487	O
,	487	488	O
fluorescein	489	500	B-Drug_or_compound
and	501	504	O
indocyanine	505	516	B-Drug_or_compound
angiography	517	528	O
and	529	532	O
optical	533	540	O
coherence	541	550	O
tomography	551	561	O
(	562	563	O
OCT	563	566	O
)	566	567	O
.	567	568	O

The	569	572	O
main	573	577	O
objective	578	587	O
of	588	590	O
the	591	594	O
study	595	600	O
was	601	604	O
to	605	607	O
determine	608	617	O
the	618	621	O
mean	622	626	O
visual	627	633	O
acuity	634	640	O
change	641	647	O
.	647	648	O

RESULTS	649	656	O
:	656	657	O
11	658	660	O
eyes	661	665	B-Organ
of	666	668	O
11	669	671	O
patients	672	680	B-Organism
were	681	685	O
included	686	694	O
in	695	697	O
the	698	701	O
study	702	707	O
,	707	708	O
which	709	714	O
had	715	718	O
a	719	720	O
mean	721	725	O
follow	726	732	O
-	732	733	O
up	733	735	O
period	736	742	O
of	743	745	O
11	746	748	O
months	749	755	O
.	755	756	O

The	757	760	O
mean	761	765	O
BCVA	766	770	O
increased	771	780	O
from	781	785	O
20	786	788	O
/	788	789	O
76	789	791	O
to	792	794	O
20	795	797	O
/	797	798	O
64	798	800	O
.	800	801	O

35	802	804	O
%	804	805	O
of	806	808	O
eyes	809	813	B-Organ
improved	814	822	O
their	823	828	O
BCVA	829	833	O
by	834	836	O
2	837	838	O
lines	839	844	O
or	845	847	O
more	848	852	O
,	852	853	O
45	854	856	O
%	856	857	O
remained	858	866	O
stable	867	873	O
and	874	877	O
18	878	880	O
%	880	881	O
lost	882	886	O
2	887	888	O
lines	889	894	O
or	895	897	O
more	898	902	O
.	902	903	O

Choroidal	904	913	O
hyperpermeability	914	931	O
was	932	935	O
reduced	936	943	O
in	944	946	O
every	947	952	O
case	953	957	O
.	957	958	O

Neurosensorial	959	973	O
retinal	974	981	B-Multi-tissue_structure
detachment	982	992	O
decreased	993	1002	O
in	1003	1005	O
80	1006	1008	O
%	1008	1009	O
of	1010	1012	O
cases	1013	1018	O
.	1018	1019	O

Only	1020	1024	O
one	1025	1028	O
eye	1029	1032	B-Organ
received	1033	1041	O
a	1042	1043	O
second	1044	1050	O
PDT	1051	1054	O
treatment	1055	1064	O
due	1065	1068	O
to	1069	1071	O
choroidal	1072	1081	O
neovascularization	1082	1100	O
.	1100	1101	O

An	1102	1104	O
increase	1105	1113	O
of	1114	1116	O
atrophy	1117	1124	O
over	1125	1129	O
the	1130	1133	O
Retinal	1134	1141	B-Tissue
Pigment	1142	1149	I-Tissue
Epithelium	1150	1160	I-Tissue
(	1161	1162	O
RPE	1162	1165	B-Tissue
)	1165	1166	O
was	1167	1170	O
observed	1171	1179	O
in	1180	1182	O
another	1183	1190	O
patient	1191	1198	B-Organism
.	1198	1199	O

CONCLUSIONS	1200	1211	O
:	1211	1212	O
PDT	1213	1216	O
can	1217	1220	O
reduce	1221	1227	O
the	1228	1231	O
clinical	1232	1240	O
signs	1241	1246	O
of	1247	1249	O
activity	1250	1258	O
,	1258	1259	O
such	1260	1264	O
as	1265	1267	O
choroidal	1268	1277	O
hyperpermeability	1278	1295	O
or	1296	1298	O
neurosensorial	1299	1313	O
retinal	1314	1321	B-Multi-tissue_structure
detachment	1322	1332	O
,	1332	1333	O
in	1334	1336	O
patients	1337	1345	B-Organism
affected	1346	1354	O
by	1355	1357	O
chronic	1358	1365	O
CSC	1366	1369	O
.	1369	1370	O

However	1371	1378	O
,	1378	1379	O
the	1380	1383	O
increase	1384	1392	O
in	1393	1395	O
visual	1396	1402	O
acuity	1403	1409	O
is	1410	1412	O
variable	1413	1421	O
,	1421	1422	O
probably	1423	1431	O
due	1432	1435	O
to	1436	1438	O
the	1439	1442	O
extent	1443	1449	O
of	1450	1452	O
RPE	1453	1456	O
damage	1457	1463	O
.	1463	1464	O

